Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

De-epithelialization reduces complications in subcutaneous skin flap procedures.

Exosomes from skin cells can boost hair growth by stimulating a gene called LEF1.

CD44 variant changes start alopecia areata, but don't maintain it.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Apigenin, found in plants and vegetables, has many health benefits, including anti-inflammatory, antioxidant, and anticancer effects.

Akkermansia muciniphila may help prevent testosterone-related hair loss.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The PI's development is closely linked to skin and hair pigmentation in macaques.

PepACS offers a safer, eco-friendly way to perm, dye, and repair hair.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Two microRNAs in stem cell exosomes help treat hair loss by targeting a specific signaling pathway.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Upadacitinib may cause hair loss.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Iontophoresis improves minoxidil delivery for alopecia treatment.

The document concludes that MGRN1 affects mouse fur color by interfering with a receptor's signaling, but its full role in the body is still unknown.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Ptprq has multiple forms that change during inner ear development.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Trps1 is essential for proper hair follicle development.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.